Nicholas J. Valeriani
Independent ChairmanMr. Nicholas J. Valeriani, also known as Nick, is Director of AgNovos Healthcare, LLC. He has been Managing Director at SPR Therapeutics, LLC since October 19, 2017. He is Director of Clyra Medical Technologies Inc. since February 2023. He serves as Director at Prominex, Inc. Mr. Valeriani served as the Chief Executive and Manager of The West Health Investment Fund. He served as Director at Roka Bioscience, Inc., since 2015 until 2018. He served as the Chief Executive at West Health since 2012 until 2015. He has executive experience in the medical device industry. He served as the Chief Executive Officer of The Gary and Mary West Health Institute from 2012 to September 2015. In this role, he had valuable expertise in engineering, operations, medical devices and diagnostics, entrepreneurship and non-profit leadership that make him uniquely qualified to advance the mission to lower health care costs through the West Health Institute, West Health Policy Center, West Health Investment Fund and West Health Incubator. He established himself as a visionary healthcare leader over his career with Johnson & Johnson which he joined in 1978 and led several corporate functions. He served as the Vice President of Strategy & Growth at Johnson & Johnson from 2007 to 2009, Group Chairman and served as its Group Chairman of Ortho-Clinical Diagnostics from 2009 to 2012. He served as the Corporate Vice President of Human Resources at Johnson & Johnson from September 2003 to 2005, Worldwide Chairman of Diagnostic since February 2004 and Worldwide Chairman of Medical Devices and Diagnostics from 2005 to 2007. He served as the Head of Office of Strategy and Growth at Johnson & Johnson since January 2008 and also served as its Worldwide Chairman of Cardiovascular Devices & Diagnostics since January 2005. He was instrumental in identifying the global healthcare trends that led to the creation of a new wellness and prevention business platform and pioneering opportunities in the area of digital health. He served as the President of Ethicon Endo-Surgery Inc., since 1997. Since January 2001, he served as Group Chairman for Ethicon Endo-Surgery with additional responsibility for Johnson & Johnson Medical Products Medical Devices and Diagnostics business. He served as the Worldwide Franchise Chairman for the DePuy Franchise since 2002. He served as Director at Surgalign Holdings, Inc. since June 2016 until 2023. He has been an Independent Director of Edwards Lifesciences Corporation since November 13, 2014 and serves as its Chairman from May 7, 2024. He was Independent Director of Sorrento Tech, Inc. from August 2015 to January 2018. He serves on the Board of Directors for the AgNovos Healthcare, Robert Wood Johnson University Hospital, Action Healthy Kids and AdvaMed. He has been a Director at SPR Therapeutics, LLC since October 19, 2017. He serves as a Director of Change Healthcare Engagement Solutions, Inc. (formerly known as Change Healthcare Corporation) and The Gary and Mary West Health Institute. He serves on the Boards of Directors of the Reagan-Udall Foundation, Reflexion Health, Inc. and the Center for Medical Interoperability. He served as a Member of the Board of Directors at The West Health Investment Fund. He served as the Chairman of the Board of Sense4Baby, Inc. Mr. Valeriani holds an MBA from Rutgers University, Graduate School of Management and a Bachelor of Science Degree in Industrial Engineering from Rutgers University, College of Engineering.
Positions
- Company NameEdwards Lifesciences CorporationStock CodeEWPositionIndependent ChairmanColleagues
- BJBernard J. ZovighianCEO & Director
- DEDonald E. BoboCorporate Vice President of Strategy & Corporate Development
- DCDaveen ChopraCorporate Vice President of Transcatheter Mitral & Tricuspid Therapies
- AMAnnette Maria BrulsCorporate Vice President of EMEA, Canada, & Latin America
- TMTheodora MistrasCorporate VP & CFO
- LSLeslie Stone HeiszIndependent Director
- PAPaul Arthur LaVioletteIndependent Director
- KTKieran T. GallahueIndependent Director
